4,4'-Dihydroxydiphenyl ether → HCID 11771333, 화합물

HRID 1294653

반응식

HRID 1294653 반응식
[OH:1][C@H:2]1[CH:7]2[CH2:8][CH2:9][N:4]([CH2:5][CH2:6]2)[CH2:3]1.[CH:10]1[C:15]([OH:16])=[CH:14][CH:13]=[C:12]([O:17][C:18]2[CH:23]=[CH:22][C:21](O)=[CH:20][CH:19]=2)[CH:11]=1>>[N:4]12[CH2:9][CH2:8][CH:7]([CH2:6][CH2:5]1)[C@@H:2]([O:1][C:21]1[CH:22]=[CH:23][C:18]([O:17][C:12]3[CH:13]=[CH:14][C:15]([OH:16])=[CH:10][CH:11]=3)=[CH:19][CH:20]=1)[CH2:3]2

참가 물질

3

반응물 2

HCID 160694,4'-Dihydroxydiphenyl etherHCID 7364113-Quinuclidinol, (+)-

생성물 1

HCID 11771333HCID 11771333, 화합물

실험 절차

3-(S)-Hydroxy-quinuclidine (the product of Reference Example 2D, 127 mg, 1 mmol) was treated with 4,4′-dihydroxydiphenyl ether (TCl, 202 mg, 1 mmol) according to the procedure of Example 1A. The title compound was purified by chromatography (SiO2, CH2Cl2:MeOH:NH3.H2O, 90:10:1, Rf. 0.2) as oil (48 mg, yield, 15%). 1H NMR (MeOH-d4, 300 MHz) δ 1.40–1.55 (m, 1H), 1.60–1.87 (m, 2H), 1.98–2.15 (m, 1H), 2.20–2.25 (m, 1H), 2.75–2.98 (m, 5H), 3.20–3.30 (m, 1H), 4.45 (m, 1H), 6.62–6.96 (m, 8H) ppm. MS (DCl/NH3) m/z 312 (M+H)+.

후처리

  1. customThe title compound was purified by chromatography (SiO2, CH2Cl2:MeOH:NH3.H2O, 90:10:1, Rf. 0.2) as oil (48 mg, yield, 15%)

출처 및 근거

ORD 기록
ord-c63beb09a43f43a093b150c61c390e5f
출처 데이터셋
uspto-grants-2007_07
특허 번호
US07241773B2

연결된 노트

불러오는 중…